To identify proteins that interact with Pak65, we used a modified form of the Sos recruitment system (SRS) [4, 5] . The Pak2 regulatory domain (PakR) was fused to the carboxyl terminus of RasL61 devoid of its membrane attachment signals (Ras(L61)∆F-PakR) and used to cotransform cdc25-2 cells with a pituitary cDNA library containing the v-Src myristoylation sequence as previously described [5] . Five galactose-dependent clones were isolated and the specificity of the interaction examined. Clones #1, #2, #5 and #6 were able to grow at 36°C when cotransformed with Ras(L61)∆F-PakR bait but not with the nonspecific bait Ras(61)∆F-JDP2, suggesting that the interaction is dependent on the PakR bait ( Figure 1a ). In contrast, clone #8 grew at 36°C when cotransformed with either bait and was subsequently shown to encode a Sos homologueSos is an acknowledged false positive in this assay [4] because when targeted to the membrane it is able to activate the yeast Ras by itself and confer growth at the restrictive temperature. Clones #1, #2 and #5 were identical and exhibited sequence homology to the GTPases Cdc42Hs and Rac1 ( Figure 1b ). As this cDNA appeared independently three times in our screen, we focused further analysis on this clone; the characterization of clone #6 will be described elsewhere.
DNA from clones #1, #2 and #5 was predicted to encode ã 36 kDa protein, designated Chp (for Cdc42Hs homologue protein), with ~52% amino acid sequence identity to Cdc42Hs. In addition to the homology to Cdc42Hs, Chp contains sequences at the amino and carboxyl termini that are not related to Cdc42Hs. An additional 28 amino acids were found at the amino terminus of Chp that are absent in Cdc42Hs, containing polyproline sequences typical of SH3-binding regions. The carboxyl terminus of Chp does not contain the classical CAAX box that is conserved among all Ras-related GTPases [6] . Instead, Chp contains an additional 32 amino acid sequence that does not share sequence homology to known proteins in the database.
Chp transcription
To determine the tissue distribution of Chp, we used a specific probe corresponding to the GTPase domain of Chp (amino acids 102-151) in northern blot analysis of mRNA from multiple rat tissues. This region exhibits only 62% identity with other members of the GTPase family. A single mRNA species of about 1.5 kb was detected at high levels in brain and testes; lower amounts were also detected in spleen and lung tissues (Figure 1c) . Interestingly, small mRNAs (1.0 kb and 1.4 kb) have been reported for other Rac-related proteins [6] . Hybridization with probes corresponding to the amino and carboxyl termini as well as full-length Chp gave similar results (data not shown).
Chp expression
For protein analyses of Chp, polyclonal antibodies were generated against a peptide corresponding to a unique region at the carboxyl terminus of Chp. To compare the size of endogenous Chp with that encoded by the cloned cDNA, we fused the Chp cDNA to a sequence encoding a Myc epitope tag and used this plasmid to overexpress Myc-Chp in 293 cells. Whole-cell extracts derived from either transfected or nontransfected 293 cells were separated on SDS-PAGE and subjected to western blotting with anti-Myc antibodies (Figure 1d , left panel). The nitrocellulose filter was subsequently incubated with affinity-purified anti-Chp antibodies (Figure 1d , right panel) to show that the transfected Chp was identical in size to the protein detected in nontransfected 293 cells using the anti-Chp antibody.
Pak65 interacts with the activated Chp mutant
PakR interacts with the activated forms of Rac and Cdc42 [7] [8] [9] [10] . On the basis of its sequence homology to Cdc42 and other Rho GTPases, we generated various Chp mutants that are expected to differ in their GDP/GTPbound state. To make a constitutively active Chp, we substituted glycine 40 with valine (G40V). The equivalent substitution in Rac and Cdc42Hs (G12V) results in an active allele that is defective in GTPase hydrolysis. In addition, we substituted amino acid 45 with asparagine. Substitution of the corresponding amino acid (at position 17) to aspargine in other Rho GTPases results in a dominant-negative allele that is locked in the GDP-bound inactive form [11] . A cdc25-2 yeast strain was cotransfected with plasmids encoding different Chp mutants fused to myristoylation sequences together with Ras(61)∆F-PakR bait. As presented in Figure 2a , constitutively active Chp (Chp Ac) and wild-type Chp, but not the dominant-negative form of Chp (Chp Dn), interacted with PakR. Sequence similarity 
Similarly, constitutively active and wild-type Cdc42Hs, but not the dominant-negative form, interact with PakR. The expression levels of the different mutants were similar (data not shown). These data suggest that the specific interaction between Chp and PakR is dependent on the activation state of the GTPase.
The role of the Chp carboxy-terminal region for Pak65 binding
To investigate the role of the Chp amino-terminal and carboxy-terminal sequences, we further mutated Chp Ac by deletion of the carboxyl or amino terminus, or both. Chp devoid of its carboxy-terminal domain was unable to bind PakR in the two-hybrid system, whereas deletion of the amino terminus had no significant effect on PakR binding (Figure 2b 
Chp selectively activates the JNK MAP kinase pathway
To test whether Chp has a similar effect to Rac and Cdc42 [11, 12] on the JNK cascade, we cotransfected 293 cells with various mutants of Chp together with haemagglutinin (HA)-tagged JNK2, extracellular-signal-regulated kinase 2 (Erk2) or p38. Both wild-type and activated forms of Chp stimulated the JNK kinase (Figure 3a) . In contrast, the dominant-negative form of Chp did not activate the
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Figure 2
Interaction of Pak65 with different Cdc42 and Chp mutants. Yeast temperature-sensitive cdc25-2 cells were transformed with the indicated plasmids and plated on glucose minimal medium supplemented with the appropriate amino acids and bases. Four independent transformants were grown at the permissive temperature, 24°C, replica plated onto appropriately supplemented galactose minimal plates and grown at the restrictive temperature, 36°C. Constructs used are described in the Supplementary material. (Figure 3b,c) . A reduction in JNK activation by tumour necrosis factor-α (TNFα) was also detected in cells transfected with dominant-negative Chp ( Figure 3d ). As described for Cdc42 and Rac GTPases [12, 13] , Chp did not significantly activate Erk2 and failed to induce the activation of the p38 kinase as well. These data suggest that Chp, in contrast to Rac and Cdc42Hs, is a selective activator of the JNK MAP kinase cascade but not of the Erk or p38 pathways.
Chp is implicated in the induction of lamellipodia
To test whether Chp has a role in the control of the actin cytoskeleton, we microinjected plasmids encoding activated Chp and stained for either Chp expression or polymerized actin. Chp was concentrated on one side of the nucleus at the Golgi apparatus and colocalized with the coatomer protein βCOP at the Golgi in the brefeldin-Asensitive compartment (data not shown). In addition, injected cells exhibited morphological changes (Figure 4 ) demonstrated by induction of lamellipodia. Interestingly, the Chp mutant in which the carboxyl terminus had been deleted failed to induce lamellipodia and Chp was not localized to the Golgi (data not shown). These data further support the role of the Chp carboxyl terminus in the localization of Chp to the Golgi and in the induction of lamellipodia, possibly through interaction with Pak2.
The data presented in this paper describe Chp as a new Rho GTPase that interacts with Pak2, that is implicated in the reorganization of the actin cytoskeleton and that activates the JNK pathway. Among the novel features of Chp are the unique amino and carboxyl termini, which are not found on any other known Rho-related GTPases and are implicated in localizing Chp and the interaction of Chp with Pak.
Supplementary material
Additional methodological details are published with this article on the internet. 
Materials and methods
Plasmids and constructs
For Chp expression vectors, mammalian expression vectors were generated by fusing Chp cDNA in frame with cDNA encoding the Myc epitope tag in the pCan mammalian expression vector. Yeast expression vectors were generated by fusion of Chp cDNA in frame with cDNA encoding the Src myristoylation signal in the pYes2 expression vector (Invitrogen Inc.). Plasmids encoding different Cdc42 mutants were subcloned into the pYes2 expression vector using standard procedures. Chp mutagenesis was performed using the Chameleon mutagenesis kit (Stratagene Inc.) according to the manufacturer's instructions.
Northern blot analysis
Northern blots were purchased from Clontech Inc. and performed as described in the manufacturer's protocols. The specific probes were generated by random primer labelling kit (Stratagene Inc.). Probes were incubated with filters for 2 hr at 68°C. The filters were washed three times with 2 × SSC containing 0.1% SDS at room temperature followed by two washes with 0.1 × SSC containing 0.1% SDS at 55°C.
Western blot analysis
Protein extracts (50 µg/lane) were resolved on an SDS-12.5% polyacrylamide gel, blotted onto nitrocellulose membrane, and probed with anti-Myc antibodies or affinity-purified Chp antibodies. Anti-mouse antibody or protein A conjugated to horseradish peroxidase were used in a secondary incubation. The nitrocellulose blots were developed using the SuperSignal chemiluminescent reaction kit (Promega Inc.).
Chp antibody was generated against the carboxyl terminus peptide 216-KLNAKGVRTLSRCRWKK-232 conjugated to Keyhole-Limpet haemocyanin (KLH). Antibody purification was carried out by coupling 10 mg of the peptide to 10 ml of agarose gel. The gel was equilibrated with PBS and the crude serum was applied to the gel, washed and antibody was eluted by glycine buffer pH 2.0.
Yeast manipulations
Conventional yeast transfection and manipulation protocols were used as described [4, 5] .
Transfection and in vitro kinase assays 293 cells were transfected using the CaPO 4 precipitation procedure. Cells were cotransfected with pCan expression plasmids driving the expression of different Chp mutants (5 µg) and Srα expression vectors driving the expression of the different HA-tagged kinases (5 µg). 48 hr following transfection, protein was extracted and in vitro kinase assays were performed as described [7] . For HA-Erk2, HA-JNK2 and HA-p38, the following purified substrates (5 µg/assay) were used respectively: myelin basic protein (MBP), GST-c-Jun 1-79, and GST-ATF2∆.
To study the effect of Chp on the activation of the JNK pathway by Src and Cdc42, we transfected HeLa cells with Chp Dn together with either Src or the activated form of Cdc42Q61 and HA-tagged JNK2. To study the effect of Chp Dn on JNK activation by TNFα, transfected cells were treated for 15 min with 10 ng TNFα/ml of media followed by in vitro kinase assay as described above.
Microinjections and immunofluorescence microscopy
Porcine endothelial (PAE) cells grown in DMEM medium containing 10% fetal bovine serum were plated on coverslips. Expression vectors encoding Myc-tagged Chp proteins were diluted to a concentration of 50 ng/µl in injection buffer (5 mM glutamate, 130 mM KCl) and microinjected into the nucleus of approximately 100 subconfluent PAE cells. Injected cells were incubated for 4-6 hr at 37°C. Cells were fixed in 4% formaldehyde in PBS for 10 min and permeabilized by washing in PBS containing 0.1% Triton X-100. For localization studies, cells were cotreated with anti-Myc monoclonal antibody and rabbit anti-βCOP (a gift from Richard Khan) for 45 min. The coverslips were then washed with PBS-TX and cotreated with FITC-conjugated donkey anti-mouse and Texas-red-conjugated donkey anti-rabbit for 30 min. For morphology studies, cells were treated with a primary antiMyc monoclonal antibody and FITC donkey anti-mouse secondary antibody. Coverslips were then washed in PBS-TX and treated for 10 min with Texas-red-conjugated phalloidin. Fluorescence microscopy was carried out using a Zeiss Axiophot with appropriate filters for fluorescence detection.
Overlay assay
Recombinant proteins (Pak2 and WASP) were separated on SDS-PAGE followed by blotting to a polyvinylidene fluoride (PVDF) membrane, washing, and blocking with PBS containing 1% BSA and 100 mM DTT. Recombinant Chp (2-5 µg) was preloaded with radiolabelled [γ-P 32 ]GTP and incubated for 5-8 min with the PVDF filter. The filter was washed for 5 min and exposed to film for 2 hr. Recombinant proteins (Chp mutants, Pak2 and WASP) were expressed as a Glu-Glu-tagged protein and purified from Sf9 cells as previously described [7] .
